Why the method name is not the conclusion

HPLC and mass spectrometry are commonly listed on peptide documentation because they provide different kinds of analytical information. Seeing either name on a COA is a reason to read further, not a reason to stop reading. The key questions are: what sample was tested, what did the method measure, what specification applied and what was actually reported?

Analytical methods support limited claims about the material tested under stated conditions. They do not, on their own, establish a product’s safety, clinical effect, handling history, sterility or suitability for human use.

What HPLC is commonly used to examine

High-performance liquid chromatography (HPLC) separates components in a sample under specified conditions. In a peptide COA, it may be used to report a chromatographic purity or related-substances result. The resulting chromatogram can show peaks that a laboratory has detected and integrated under that method.

A useful HPLC-related entry identifies the method or method reference, the result, the acceptance criterion and preferably the lot or sample identifier. A COA that says only “HPLC tested” gives far less information than one that states a result against a defined specification.

What mass spectrometry can indicate

Mass spectrometry measures ions by mass-to-charge ratio. On peptide documentation, it is often used as part of an identity check: the observed mass can be compared with the mass expected for the stated material. It can be useful supporting evidence that a tested sample is consistent with the named molecule.

However, a matching mass alone does not establish every structural detail, every impurity, every concentration or every property of the material. It also does not replace lot traceability. The value of an identity result depends on knowing which sample was measured and how the result was interpreted.

Read the two methods as complementary, not interchangeable

QuestionHPLC may help addressMass spectrometry may help address
Does the sample contain separable components?Yes, under the stated chromatographic method.Not primarily.
Is the observed mass consistent with the stated material?Not primarily.Often, as part of an identity assessment.
What is the reported purity result?Often used for a stated chromatographic purity result.Not automatically.
Does this prove the product is safe or clinically effective?No.No.

The exact application depends on the laboratory’s validated procedure, sample preparation and reporting rules. Avoid inferring more than the report states.

Four details worth looking for on the COA

  1. Lot or sample identity. The analytical result should connect to the product lot, not merely a generic product name.
  2. Method information. Look for a method name, number or enough detail to distinguish identity work from a purity result.
  3. Specification and result. A stated limit plus the observed number is more meaningful than an isolated percentage.
  4. Laboratory and report traceability. Record the issuer, test date and report identifier. If third-party testing is claimed, see whether the laboratory and original report can be identified.

Common overreadings

  • “HPLC = pure.” A method label does not tell you the integration settings, specification, reportable range or whether the displayed document belongs to the current lot.
  • “Mass spec = complete identity.” An observed mass can support an identity assessment, but does not independently resolve every possible structural or quality question.
  • “99% = everything else is known.” The unreported fraction may require separate analysis to characterize, and a single purity result does not answer questions the method did not test.
  • “One COA verifies a whole supplier.” A lot-specific result is evidence for the documented lot and scope. It does not replace broader evidence about documentation practices or other lots.

Use method names to ask better questions

A careful reader does not need to become an analytical chemist to improve a supplier comparison. If a COA says HPLC, ask what result and specification are shown. If it says mass spectrometry, ask whether the report links the observed result to the named sample. If it claims third-party testing, ask whether the issuing laboratory and record can be verified.

Those questions lead to more useful conclusions than a simple “tested” or “not tested” label.

Place the COA in the wider evidence record

For a complete reading workflow, begin with How to Read a Peptide COA, then use How to Evaluate Peptide Supplier Information to keep supplier claims, records and unresolved gaps separate. Our Supplier Evidence Checklist can help record what is present and what still needs verification.

Sources and further reading